Form 8-K - Current report:
SEC Accession No. 0001493152-26-022610
Filing Date
2026-05-13
Accepted
2026-05-13 07:30:50
Documents
33
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38869
2 EX-99.1 ex99-1.htm EX-99.1 67462
3 EX-99.2 ex99-2.htm EX-99.2 17902
4 GRAPHIC ex99-1_001.jpg GRAPHIC 4127
5 GRAPHIC ex99-2_001.jpg GRAPHIC 385982
6 GRAPHIC ex99-2_002.jpg GRAPHIC 708472
7 GRAPHIC ex99-2_003.jpg GRAPHIC 107752
8 GRAPHIC ex99-2_004.jpg GRAPHIC 235934
9 GRAPHIC ex99-2_005.jpg GRAPHIC 107190
10 GRAPHIC ex99-2_006.jpg GRAPHIC 252400
11 GRAPHIC ex99-2_007.jpg GRAPHIC 236288
12 GRAPHIC ex99-2_008.jpg GRAPHIC 225582
13 GRAPHIC ex99-2_009.jpg GRAPHIC 110777
14 GRAPHIC ex99-2_010.jpg GRAPHIC 237251
15 GRAPHIC ex99-2_011.jpg GRAPHIC 300174
16 GRAPHIC ex99-2_012.jpg GRAPHIC 312307
17 GRAPHIC ex99-2_013.jpg GRAPHIC 348013
18 GRAPHIC ex99-2_014.jpg GRAPHIC 396160
19 GRAPHIC ex99-2_015.jpg GRAPHIC 100103
20 GRAPHIC ex99-2_016.jpg GRAPHIC 198982
21 GRAPHIC ex99-2_017.jpg GRAPHIC 103936
22 GRAPHIC ex99-2_018.jpg GRAPHIC 277909
23 GRAPHIC ex99-2_019.jpg GRAPHIC 80255
  Complete submission text file 0001493152-26-022610.txt   6817747

Data Files

Seq Description Document Type Size
24 XBRL SCHEMA FILE abeo-20260513.xsd EX-101.SCH 3044
25 XBRL LABEL FILE abeo-20260513_lab.xml EX-101.LAB 34239
26 XBRL PRESENTATION FILE abeo-20260513_pre.xml EX-101.PRE 22378
36 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3207
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 26970940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)